It's not the money - Pfizer GC Amy Schulman on hitting budget and not missing the billable hour
A year ago, as the client-to-law-firm conversation had fully entered its give-me-a-discount or give-me-death phase, The American Lawyer put Amy Schulman, Pfizer's general counsel, on its cover. Fresh from a stint as an enormously successful DLA Piper litigation partner, Schulman had a different idea about how customers and lawyers should relate to each other. Building on work done at EI DuPont and de Nemours, at United Technologies and by her Pfizer predecessors, she abandoned the billable hour, created an alliance of 19 law firms that would get a disproportionate share of her $500m (£322m) budget and insisted that the lawyers find new ways of assessing the value of the work they did. All that, and save 15% off the top.
Catching up with Pfizer GC Amy Schulman a year after her radical shake-up of the client/adviser relationship, Aric Press finds her hitting budget and not missing the billable hour
This premium content is reserved for
Legal Week Subscribers.
Subscribe today and get 10% off.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Unique access to ALM's unrivalled, market-leading reporting in the US and Asia and cutting-edge research, including Legal Week's UK Top 50 and Global 100 rankings
- The Legal Week Daily News Alert, Editor's Highlights, and Breaking News digital newsletters and more, plus a choice of over 70 ALM newsletters
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now
For enterprise-wide or corporate enquiries, please contact Paul Reeves on Preeves@alm.com or call on +44 (0) 203 875 0651